INS and COVID-19: Wang D et al also noted that insulin therapy is associated with higher mortality rates in COVID-19 patients with type 2 diabetes, which supports our hypothesis that P goldsteinii increases COVID-19 susceptibility by reducing insulin resistance.[38]